Health
Ask A Vaccine Specialist: What Does The Future of the mRNA Platform Hold? – The Motley Fool
Its use in a coronavirus vaccine is an exciting step forward, but mRNA technology is unlikely to solve all of our problems.
Recently authorized coronavirus vaccines from Moderna (NASDAQ:MRNA) and the Pfizer(NYSE:PFE)-BioNTech(NASDAQ:BNTX) team are the first messenger RNA (mRNA) vaccines ever to be commercialized. Dr. Bruce Gellin of the Sabin Vaccine Institute joined Corinne Cardina and Olivia Zitkus of Fool.com’s Healthcare and Cannabis Bureau on a Dec. 18 episode of Fool Live to talk about some of the possibilities of the mRNA platform in vaccine and drug development.
Olivia Zitkus: As an expert on these vaccines,…
-
Business20 hours agoHow to choose your first ASX ETF
-
Business22 hours agoAged 30 and earning an average wage? You’re now set up for retirement. Here’s how
-
Business19 hours agoHow to earn $100 a month of passive income from ASX dividends
-
Noosa News19 hours agoGelato Messina and Tony’s Chocolonely Have Collabed on a Super Gooey Bake-At-Home Cookie Pie Perfect for Cold Winter Nights